Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

被引：0
|
作者：
Vanhove, Thomas [1 ]
Annaert, Pieter [2 ]
Kuypers, Dirk R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Nephrol & Renal Transplantat, Leuven, Belgium
[2] Univ Leuven, KU Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
420.13
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [1] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, T.
    Annaert, P.
    Lambrechts, D.
    Kuypers, D. R. J.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (06): : 556 - 562
  • [2] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    T Vanhove
    P Annaert
    D Lambrechts
    D R J Kuypers
    The Pharmacogenomics Journal, 2017, 17 : 556 - 562
  • [3] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [4] IMPACT OF CYP3A5, CYP3A4 AND MDR1 GENE POLYMORPHISMS ON TROUGH CONCENTRATIONS OF TACROLIMUS, CYCLOSPORINE AND SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Shi, Yunying
    Li, Yi
    Cai, Bei
    Cai, Bei
    Zou, Yuangao
    Tao, Ye
    Wang, Lanlan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [5] The distribution of MDR1, CYP3A4 and CYP3A5 genotypes in a polish heart transplant recipients
    Kunicki, Pawel K.
    Sobieszczanska-Malek, Malgorzata
    Gmik, Wanda
    Drozdzik, Marek
    Adler, Grazyna
    Ciechanowicz, Andrzej
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 545 - 545
  • [6] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [7] CYP3A5 and CYP3A4 but not MDR1 single-nucleotide Polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients
    Kuypers, D. R. J.
    de Jonge, H.
    Naesens, M.
    Lerut, E.
    Verbeke, K.
    Vanrenterghem, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (06) : 711 - 725
  • [8] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [9] Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus
    Chen, J. S.
    Li, L. S.
    Cheng, D. R.
    Ji, S. M.
    Sun, Q. Q.
    Cheng, Z.
    Wen, J. Q.
    Sha, G. Z.
    Liu, Z. H.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1557 - 1561
  • [10] Effect of CYP3A4*22 and CYP3A5 Combined Genotypes on Tacrolimus Disposition in Heart Transplantation
    Vu, A.
    Page, R. L.
    Roscoe, N.
    Lindenfeld, J. A.
    Aquilante, C. L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S115 - S116
12345